INNOVATORS FOR TYPE 1 DIABETES
(Photo 10)
Click on the logo to access JDRF's website
JDRF is a significant supporter for Diabetic Research. Through its Industry Discovery and Development Partnership program, they are supporting the second part of a Phase ll trial in New Zealand of LCT's DIABECELL product. This product comprises encapsulated islet cells derived from specially bred pigs. This product is being tested through a clinical trial with the purpose of preventing hypoglycemia through sensing blood glucose levels and secreting insulin accordingly. (Photo 63) (Citation 36)
JDRF is a significant supporter for Diabetic Research. Through its Industry Discovery and Development Partnership program, they are supporting the second part of a Phase ll trial in New Zealand of LCT's DIABECELL product. This product comprises encapsulated islet cells derived from specially bred pigs. This product is being tested through a clinical trial with the purpose of preventing hypoglycemia through sensing blood glucose levels and secreting insulin accordingly. (Photo 63) (Citation 36)
JDRF is a substancial innovator for supporting Type 1 Diabetes.
They are known for:
-
Improving the qualitity of life for Diabetics through treatment and prevention
-
Supporting Technological Innovations, such as new upgrades in pumps, meters, and other devices to make diabetic maintenance simpler and more efficient
-
Endeavors to find a cure through research
-
Fundraising-Anyone can partner with JDRF to help find a cure
-
Their positive outlook on the future gives diabetics hope for a non-finger prick life (Citation 6)
NIH
(National Institutes of Health)
-
It is the nation's medical research agency.
-
Contains 27 Institutes and Center to focus on different diseases and particular body systems
-
Research worldwide endeavor to help save lives and cure diseases
-
Largest source of funding for research globally (Citation 7)
(Photo 11)
Click on the logo to access NIH's website
Harvard Medical School
-
Launches a series of contests in health related innovations
-
"Innovation contests have incentivized cross-disciplinary knowledge sharing and solution development for scientific problems in non-academic communities"(Citation 8).
-
These contests have solicited ordinary people who do not know background scientific knowledge about Type 1 Diabetes, but it gives them an opportunity to pitch any ideas they may have to help solve a problem related to the disease.
-
It is supported by an ARRA grant,several Harvard University schools and InnoCentive.com (a global platform for innovation contests) (Citation 8)